Aemetis (NASDAQ:AMTX) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Aemetis (NASDAQ:AMTXGet Free Report) posted its earnings results on Tuesday. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09, Zacks reports. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter last year, the business earned ($0.59) earnings per share.

Aemetis Trading Down 3.9 %

NASDAQ AMTX traded down $0.16 on Thursday, reaching $3.97. 323,835 shares of the company were exchanged, compared to its average volume of 804,479. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03. The stock has a market capitalization of $187.37 million, a P/E ratio of -1.83 and a beta of 1.23. The business’s fifty day moving average price is $2.73 and its 200 day moving average price is $3.06.

Analysts Set New Price Targets

AMTX has been the topic of a number of recent analyst reports. HC Wainwright reiterated a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Friday, August 2nd. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Wednesday, July 31st. Ascendiant Capital Markets decreased their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. Truist Financial reiterated a “hold” rating and set a $3.50 price objective (down from $4.00) on shares of Aemetis in a research note on Wednesday, July 31st. Finally, UBS Group decreased their target price on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research report on Monday, August 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Get Our Latest Report on AMTX

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Featured Stories

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.